INFORMATION FOR PATIENTS
Theranostics represents a combinatorial diagnosis and therapeutic approach to cancer disease and aims to eliminate multi-step procedures, reduce delays in treatment and improve patient care. It offers various advantages like improved diagnosis, tumour specific delivery of drugs, reduced lethal effects to normal tissues etc.
OncoDNA was founded by a team with over 60 years’ expertise in medical diagnostics and patient care. Today, by combining the latest sequencing and pathology technologies with clinical knowledge, OncoDNA is perpetuating the tradition of excellence in the field of cancer theranostics.